Use of fast‐acting insulin aspart in insulin pump therapy in clinical practice

Fast‐acting insulin aspart (faster aspart) is a novel formulation of insulin aspart (IAsp) containing the additional excipients niacinamide and L‐arginine. The improved pharmacological profile and greater early glucose‐lowering action of faster aspart compared with IAsp suggests that faster aspart m...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Diabetes Obes Metab
Huvudupphovsmän: Evans, Mark, Ceriello, Antonio, Danne, Thomas, De Block, Christophe, DeVries, J. Hans, Lind, Marcus, Mathieu, Chantal, Nørgaard, Kirsten, Renard, Eric, Wilmot, Emma G.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Blackwell Publishing Ltd 2019
Ämnen:
Review Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6773364/
https://ncbi.nlm.nih.gov/pubmed/31144428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13798
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk